Skip to main content

and
  1. Article

    Open Access

    cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer

    Epidemiologic studies have associated obesity with increased risk of the aggressive basal-like breast cancer (BBC) subtype. Hepatocyte growth factor (HGF) signaling through its receptor, cMET, is elevated in o...

    Alyssa J. Cozzo, Sneha Sundaram, Ottavia Zattra, Yuanyuan Qin in SpringerPlus (2016)

  2. No Access

    Article

    Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

    Ovarian clear-cell carcinoma (OCCC) is an aggressive form of ovarian cancer with high ARID1A mutation rates. Here we present a mutant mouse model of OCCC. We find that ARID1A inactivation is not sufficient for tu...

    Ronald L. Chandler, Jeffrey S. Damrauer, Jesse R. Raab in Nature Communications (2015)